Mold Test Kits Home
Categories
Submit Press Release
Order Credits
Archive
01-19-2017 03:14 PM C ET - Business, Economy, Finances, Banking & Insurance
News / Feeds
Global Irbesartan (CAS 138402-11-6) Market 2016 - Sanofi, Taj Pharmaceuticals, Unichem Laboratories, Divis Laboratories, Zhejiang Tianyu, Zhuhai Rundu, Zhejiang Kinglyuan Press release from: Fior Markets
Mold Test Kits Irbesartan (INN) is an angiotensin II receptor antagonist used mainly for the treatment of hypertension. It w as developed by Sanofi Research (now part of Sanofi-Aventis). It is jointly marketed by Sanofi-Aventis and Bristol-Myers Squibb under the trade names Aprovel, Karvea, and Avapro. Dow nload sample report at w w w .fiormarkets.com/reportdetail/10891/request-sample This report provides detailed analysis of w orldw ide markets for Irbesartan (CAS 138402-11-6) from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Irbesartan (CAS 138402-11-6) market and further lays out an analysis of the factors influencing the supply/demand for Irbesartan (CAS 13840211-6), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.
About Us
Search
GO
More Releases from Fior Markets Global Olmesartan Medoxomil CAS 144689 63 4 Market 2016 Daiichi Sankyo Taj Pharmaceuticals Divis Laboratories Amoli Organics Lupin Zhejiang Tianyu Zhuhai Rundu Global Candesartan Cilexetil CAS 145040 37 5 Market 2016 Takeda Pharmaceutical Taj Pharmaceuticals Lupin Zhejiang Tianyu Zhuhai Rundu TIPR Pharmaceutical Global Valsartan CAS 137862 53 4 Market 2016 Novartis Pharma Taj Pharmaceuticals Divis Laboratories Zhejiang Tianyu Zhuhai Rundu Zhejiang Kinglyuan Shanghai Kony All 928 Releases
Comments about openPR I can't but agree to the positive statements about your portal: easy to use, clear layout, very good search function, and quick editing! Jens O'Brien, Borgmeier Media Communication
W ith PDFmyURL anyone can convert entire websites to PDF!
Global Irbesartan (CAS 138402-11-6) Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Irbesartan (CAS 138402-11-6) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. Access full report at w w w .fiormarkets.com/report/global-irbesartancas-138402-1... The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Irbesartan (CAS 138402-11-6) market are Sanofi (France), Taj Pharmaceuticals (India),Unichem Laboratories (India), Divis Laboratories (India), Zhejiang Tianyu (China), Zhuhai Rundu (China), Zhejiang Kinglyuan (China), among others. The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of W orld. In this sector, global competitive landscape and supply/demand pattern of Irbesartan (CAS 138402-11-6) industry has been provided. Fior Markets is a leading market intelligence company that sells reports of top publishers in the technology industry. Our extensive research reports cover detailed market assessments that include major technological improvements in the industry. Fior Markets also specializes in analyzing hi-tech systems and current processing systems in its expertise. Contact Us Mark Stone Sales Manager Phone: (201) 465-4211 Email: sales@fiormarkets.com This release was published on openPR.
News-ID: 417402 More releases
W ith PDFmyURL anyone can convert entire websites to PDF!
Your Press Releases on Google News
openPR.de
Permanent link to this press release:
http://www.ope npr.com /ne ws/417402/Globa l-Irbe sa rta n-C AS-138402-11-6-Ma rk e t-2016-Sa nofi-Ta j-P ha rm a ce utica ls-Uniche m -La bora torie s-Divis-La bora torie s-Zhe jia ng-Tia nyu-Zh P le a se se t a link in the pre ss a re a of your hom e pa ge to this pre ss re le a se on ope nP R . ope nP R discla im s lia bility for a ny conte nt conta ine d in this re le a se .
Share
(0 )
Y ou can edit or delete your press release here: Delete press release
Edit press release
To top
W ith PDFmyURL anyone can convert entire websites to PDF!
© openPR 2017 | Imprint